-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Phathom Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2019 to Q1 2024.
- Phathom Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$69M, a 74% decline year-over-year.
- Phathom Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$267M, a 93.9% decline from 2023.
- Phathom Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$138M, a 6.11% increase from 2022.
- Phathom Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$147M, a 1.3% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)